News
Iktos and Elsevier announce their partnership
Iktos and Elsevier partner to deliver a predictive retrosynthesis and synthetic accessibility platform. Combining the...
Iktos opens Japan subsidiary and entrusts its management to Hideyoshi Fuji
Iktos announces the opening of its subsidiary in Japan and entrusts its management to Hideyoshi Fuji as Representative...
Iktos announces the appointment of Avirup Bose as CBO
Iktos announces the appointment of Avirup Bose as Chief Business Officer. At Iktos, Avirup will lead the global...
Collaboration: Iktos and Nerviano Medical Sciences S.r.l
Iktos and Nerviano Medical Sciences S.r.l (NMS), a leading Italian clinical stage biotech discovering and developing...
Iktos and Bayer Announce Collaboration in AI
Iktos and Bayer’s Crop Science division with its industry-leading R&D pipeline and portfolio of seeds &...
Big Data & AI For Good Prize: 12th Big Data & AI Paris Congress
We are thrilled to announce that Iktos has won the "Big Data & AI for Good" prize at the 12th edition of the Big...
Kissei Pharmaceutical Introduces Iktos AI Drug Discovery System
Iktos announces that Kissei Pharmaceutical Co., Ltd., a Japanese pharmaceutical company with approximately 75 years of...
Collaboration with Curreio, Inc. in New Drug Discovery
Iktos announces a collaboration with Curreio, Inc., a Japanese company specializing in structural analysis of...
Iktos announces closing of €15.5M in Series A round
Iktos raises € 15.5m Series A round to expand its artificial intelligence-based drug discovery technologies and...
Partnership with MMV in Anti-Malarial Drug Discovery
Iktos announces a collaboration with Medicines for Malaria Venture (MMV), a leading product development partnership...
Collaboration With Galapagos in AI For Drug Design
Iktos announces a collaboration deal with Galapagos, a leading global biopharmaceutical company focused on the...
Iktos & Zealand Pharma to Develop AI Technology for Peptide Drug Design
Iktos today announced a research collaboration with Zealand Pharma A/S, a biotechnology company changing lives with...
Collaboration with Sygnature Discovery in AI for New Drug Design
Iktos and Sygnature Discovery announce their collaboration in Artificial Intelligence for de novo drug design. Under...
Iktos and Teijin Pharma to Co-Develop New Technology for Small Molecule Drug Discovery
Iktos and Teijin Pharma Limited, the core company of the Teijin Group’s healthcare business that provides...
Collaboration With Ono in Artificial Intelligence for New Drug Design
Iktos announces a collaboration agreement with Ono Pharmaceuticals Co., Ltd., a leading pharmaceutical company based...
Collaboration with Astrogen to Use AI Platform
Iktos and Astrogen have entered into a research collaboration agreement aimed at discovery of innovative small...
Collaboration with The University of Dundee to Use AI
Under the agreement, Iktos will apply its de novo ligand and structure-based generative modeling technologies, its...
Collaboration with Jiangsu Hengrui Pharmaceuticals Co. Ltd.
Iktos announces deployment of our AI for drug design software Makya™ by Jiangsu Hengrui Pharmaceuticals Co., Ltd....
Collaboration with Chiesi Group to use Makya™ for Drug Discovery
Iktos announces deployment of our AI for drug design software Makya™ by Chiesi Group. Follow the link for the full...
Collaboration with UCB in AI for Retrosynthesis
Iktos announced a software licensing agreement related to AI-based retrosynthesis analysis and planning tool Spaya™ ,...
Collaboration with Kadmon
Iktos announces that it has entered into a Research Collaboration Agreement with Kadmon, a clinical-stage...
Collaboration with Facio Therapies
Iktos and Facio Therapies announce collaboration to use AI for FSHD drug design. Follow the link for the full press...
Collaboration With Pfizer in AI for Drug Design
Iktos announces the application of Iktos Artificial Intelligence technology for de novo design to selected Pfizer...
Collaboration With Merck KGaA
Iktos announces an additional collaboration agreement in AI for new drug design with Merck KGaA, Darmstadt, Germany, a...
Collaboration with SRI International
Iktos and SRI International announce collaboration to combine Artificial Intelligence and novel automated discovery...
Collaboration with Almirall
Iktos and Almirall announce research collaboration in Artificial Intelligence for new drug design. Follow the link for...
Research Collaboration with Janssen
Iktos announces research collaboration with Janssen to utilise Iktos’s Artificial Intelligence (AI) technology to...
Collaboration with Merck KGa
Iktos announces collaboration with Merck KGaA, Darmstadt, Germany, for use of Iktos AI technology across three drug...
Collaboration with Servier
Iktos and Servier announce the success of their first collaboration, which was designed to evaluate Iktos technology’s...